Enfiera 100mg Injection

Description

Enfiera 100mg Injection contains Rituximab, a monoclonal antibody that specifically targets CD20 proteins on the surface of B-cells, a type of white blood cell involved in the immune response. By binding to CD20, Rituximab helps destroy abnormal or malignant B-cells, making it highly effective in the treatment of certain cancers and autoimmune diseases.

Rituximab is widely used in hematological malignancies, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as in autoimmune conditions like rheumatoid arthritis. Its mechanism allows for targeted therapy, which helps in reducing the proliferation of disease-causing cells while minimizing impact on healthy cells.

Enfiera 100mg Injection is administered intravenously under medical supervision, often in a hospital or infusion center due to the risk of infusion reactions.

---

Uses of Enfiera 100mg Injection

• Hematological cancers:

  • Non-Hodgkin lymphoma (NHL)

  • Chronic lymphocytic leukemia (CLL)

• Autoimmune disorders:

  • Rheumatoid arthritis (in combination with methotrexate)

  • Certain vasculitis and autoimmune cytopenias

• Other off-label uses under specialist supervision for conditions involving abnormal B-cell activity

---

How It Works

• Rituximab binds to the CD20 antigen on B-cells.

• This triggers cell-mediated cytotoxicity and apoptosis (programmed cell death) of targeted B-cells.

• Reduction in abnormal B-cells helps control tumor growth in cancers and modulate immune responses in autoimmune diseases.

• Provides a targeted approach, sparing most non-B-cells from damage.

---

Dosage and Administration

• Administered intravenously by trained healthcare professionals.

• Dose depends on:

  • Patient’s weight and body surface area

  • Specific disease being treated

  • Concomitant medications or combination therapies

• Usually given in cycles, with premedication to reduce infusion-related reactions.

• Patients are monitored during and after infusion for allergic or infusion reactions.

---

Side Effects

Common side effects:

• Fever, chills, and fatigue during or after infusion

• Nausea or vomiting

• Mild headache or dizziness

• Sore throat or cough

Serious side effects (rare):

• Severe infusion reactions (difficulty breathing, rash, hypotension)

• Infections due to immunosuppression

• Low blood cell counts (anemia, leukopenia, thrombocytopenia)

• Reactivation of hepatitis B in carriers

• Cardiac complications in sensitive patients

Immediate medical attention is required for serious reactions.

---

Precautions

• Use only under strict medical supervision in a hospital or infusion center.

• Patients should be screened for hepatitis B and C before starting therapy.

• Avoid live vaccines during treatment due to immune suppression.

• Inform the doctor of all medications and pre-existing conditions.

• Pregnant or breastfeeding women should use only if prescribed and monitored.

---

Drug Interactions

• Other immunosuppressants or chemotherapy agents – may increase risk of infections or toxicity

• Live vaccines – contraindicated during treatment

• Certain biologics or monoclonal antibodies – may increase immune suppression

All concomitant therapies must be discussed with the treating physician.

---

Storage Instructions

• Store between 2–8°C; do not freeze.

• Protect from light and agitation.

• Use immediately after preparation as per manufacturer guidelines.

• Keep out of reach of children.

---

Key Benefits of Enfiera 100mg Injection

• Provides targeted therapy against B-cell malignancies and autoimmune diseases

• Helps reduce tumor burden and control abnormal immune activity

• Administered under controlled conditions to ensure safety and efficacy

• Can be used in combination with chemotherapy or other immunosuppressive drugs